• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
MRI Image of Brain

Christopher Martin, a stroke survivor, has made a remarkable recovery following his participation in the Neurologic Stem Cell Treatment Study. The consequences of his hemorrhagic stroke in April 2016 were terrible. Martin reports: “ I pretty much went straight into atrophy and spasticity. I could hardly do anything with my right side. My shoulder was subluxed and I wore a Kafo orthosis and a shoulder brace. I hated every minute of my life”.

Martin began to work out as much as he could in July 2019, but soon realized he needed something more to overcome the stroke. He decided to look at the latest stem cell treatment options from the Neurologic Stem Cell Treatment Study (NEST) on clinicaltrials.gov. He took part in the NEST program in October 2020. Within about 4 months he reported noticing major increases in muscle strength as the neurons damaged in the stroke began to recover and regenerate.

"I lost probably 90% of those neurons/ muscles from the stroke," Martin said. "I am now regenerating all those muscles back in 2.5-3 years. It's remarkable. Now I walk pretty normally. Everything is working better."

Martin's story is a testament to the power of neurologic advances, synergistic with exercise, to promote stroke recovery. By harnessing the stem cell fraction in NEST, he was able to jump-start his recovery, regain strength and is now much better able to walk and move.
His story is an inspiration to stroke survivors everywhere, showing that significant improvement may be possible using cutting-edge approaches in neurology. With the willingness to embrace new technology, patients suffering from different neurologic diseases may make remarkable progress toward normalcy.

The Neurologic Stem Cell Treatment Study ( NEST) NCT02795052 uses the patient's own stem cells for treatment. The patient is provide a short period of anesthesia and there is no pain. A small amount of the patient’s own bone marrow is taken, the stem cell fraction is isolated, and the stem cells are provided intravenously and intranasally, passing readily through the circulation and bypassing the blood-brain barrier to non-invasively enter the brain and central nervous system.

MD Stem Cells has treated a number of neurologic diseases in NEST. Eligible conditions as listed in ClinicalTrials.gov include: Neurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases, Neurological Disorders, Stroke, Traumatic Brain Injury, Cadasil, Chronic Traumatic Encephalopathy, Cerebral Infarction, Cerebral Ischemia, Cerebral Stroke, Cerebral Hemorrhage, Parkinson, Multi-System Degeneration MSA , Multiple System Atrophy, Progressive Supranuclear Palsy PSP, Amyotrophic Lateral Sclerosis ALS, Neuropathy, Diabetic Neuropathies, Alzheimer Disease, Dementia, Frontotemporal Dementia, Lewy Body Disease, Cognitive Impairment, Lewy Body Variant of Alzheimer Disease.

Company Name: MD Stem Cells
About Company: MD Stem Cells is the sponsor of specialty clinical studies and treatments involving Ophthalmology, Neurology, Alzheimer's Disease, Dementias, Autism Spectrum Disorder, Spinal Cord Injury and Anti-Aging. Our success stems from years of effort first in Europe and, beginning in 2012, with US based, FDA compliant, IRB approved and NIH registered studies. MD Stem Cells provides the only stem cell treatments in ophthalmology with medical journal published, statistically significant results. That means eligible patients can enroll in a study with scientifically proven results right now. We use only adult, bone marrow derived stem cells - never adipose, fat, or embryonic derived cells. Our proprietary approaches maximize yield and effectiveness. With hundreds of patients having participated and significant numbers having meaningful improvements, we hope you take a careful look at our experience and results.
Person of Contact: Steven Levy
Designation: MD